CA9 and Clear Cell Meningioma: The authors proposed that CA IX immunostaining could be of potential value with other markers, such as CD10 and renal cell carcinoma antigen, for differential diagnostics of clear cell meningiomas from metastatic clear cell renal cell carcinoma.